Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

Delayed Upgrade Clock